Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDODS.L Regulatory News (DODS)

  • There is currently no data for DODS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

6 Dec 2005 07:01

Huveaux PLC06 December 2005 6 December 2005 HUVEAUX PLC PRE-CLOSE TRADING UPDATE Huveaux PLC, the publishing and media group, today provides the followingpre-close trading update: Huveaux has doubled in size during 2005 through a combination of both organicand acquisition-led growth and trading to date suggests a good out-turn for thecurrent financial year. The Political Division has achieved underlying 11% organic sales growth in the11 month period to 30 November. The controversial programme of reform by the UKGovernment and the EU Parliament continues to drive increased revenueopportunities across the Division's political publications and other mediachannels. The Learning Division has been significantly strengthened with the recentacquisition of the e-learning business, Epic Group PLC, which was completed on22 August. The integration of Epic is progressing well, with sales in line withexpectations and November orders particularly strong in the public sector. Themargins and profits from Epic during the last few months of the year have beenslightly higher than budgeted. The remainder of the Learning Division is tradingin line with expectations. The Professional Division consists principally of the recently acquired JBBSante, a leading publisher of medical magazines in France. This acquisition wascompleted on 5 October, a month later than planned. However, the integration ofJBB is also progressing well and trading is in line with expectations. JBB willdeliver a strong contribution to the Group's profits this year. As previously indicated, the restructuring costs associated with the integrationof both Epic and JBB Sante into the Group will be taken as an exceptional itemand are expected to be within analysts' estimates. Taken as a whole, the Board expects that Huveaux's sales and operating profitfor 2005, before exceptional items, will be in line with analysts' expectations. The Company intends to announce its Preliminary Results for the financial yearending 31 December 2005 in early March 2006. For further information, please contact: Huveaux PLC John van Kuffeler, Executive Chairman 0207 245 0270 Finsbury James Leviton 0207 251 3801Don Hunter Notes for Editors re Huveaux background: Huveaux was formed in 2001 with the objective of building, over the next 10years, a substantial publishing and media group through an appropriate balanceof acquisition-led and organic growth. Huveaux is focussed on the creation anddelivery of customer-critical information across both the public and privatesectors. Since being admitted to AIM in December 2001, the Company has successfullycompleted the acquisition of nine complementary businesses. It is the marketleader in political publishing and e-learning in the UK and one of the leadingmedical publishers in France. The Huveaux Group now consists of three Divisions: Political, Learning andProfessional which comprise a mix of magazines, websites, databases, referencebooks, revision guides, manuals, videos, conferences, seminars and events in theB2B sector. Huveaux has offices in London, Paris and Brussels as well as threeregional UK offices. Huveaux was founded by John van Kuffeler, formerly Chief Executive and nownon-executive Chairman of Provident Financial plc. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
20th Apr 20214:05 pmRNSHolding(s) in Company
16th Apr 202111:30 amRNSResult of General Meeting
1st Apr 20217:00 amRNSPosting of Circular and Notice of GM
30th Mar 20217:01 amRNSChange of Name and Share Capital Reorganisation
30th Mar 20217:00 amRNSTrading Update
30th Nov 20207:00 amRNSHalf-year Report
26th Nov 202011:35 amRNSBoard Changes
12th Oct 20204:23 pmRNSHolding(s) in Company
29th Sep 202012:21 pmRNSResult of AGM
4th Sep 202012:31 pmRNSAnnual Financial Report
3rd Sep 20207:02 amRNSFinal Results
3rd Sep 20207:00 amRNSAppointment of Nominated Adviser and Sole Broker
5th Aug 20202:02 pmRNSHolding(s) in Company
29th Jul 20207:00 amRNSIssue of Shares and Director / PDMR Dealing
1st Jul 202010:52 amRNSDirectorate Change
18th Jun 20207:00 amRNSDr David Hammond
1st Jun 20202:06 pmRNSBoard Appointments
1st Jun 20207:00 amRNSUpdated Debt Facilities
23rd Apr 20207:06 amRNSAppointment of CFO and COVID-19 Update
18th Mar 20205:46 pmRNSAIM Rule 17 Notification
24th Feb 20203:47 pmRNSDirectorate Change
22nd Jan 20202:52 pmRNSDirectorate Change
22nd Jan 20207:00 amRNSTrading Update
29th Oct 20197:00 amRNSHalf-year Report
26th Sep 20197:00 amRNSChange of Adviser
25th Sep 20198:59 amRNSAIM Rule 17 Schedule Two (g) Update
2nd Sep 20197:00 amRNSDirectorate Change
29th Aug 20194:07 pmRNSResult of AGM
23rd Jul 20197:00 amRNSHolding(s) in Company
23rd Jul 20197:00 amRNSHolding(s) in Company
18th Jul 20191:42 pmRNSCompletion of Acquisition
18th Jul 20198:48 amRNSDirector/PDMR Shareholding
18th Jul 20198:46 amRNSAnnual Financial Report
16th Jul 201910:39 amRNSResult of General Meeting and Open Offer
28th Jun 20198:47 amRNSGeneral Meeting & Open Offer Timetable
28th Jun 20197:00 amRNSFinal Results
28th Jun 20197:00 amRNSAcquisition, Fundraising and Notice of GM
11th Jun 20197:00 amRNSAcquisition of Meritgroup
10th Jun 20197:00 amRNSResponse re. Press Speculation
21st May 20197:00 amRNSAppointment of Chief Revenue Officer
29th Apr 20197:00 amRNSAppointment of Chief Information Officer
21st Jan 20197:00 amRNSTrading Statement
5th Dec 20181:50 pmRNSHolding(s) in Company
5th Dec 20181:50 pmRNSHolding(s) in Company
14th Nov 20187:00 amRNSHalf-year Report
21st Sep 201811:17 amRNSLong Term Incentive Plan
14th Aug 201812:39 pmRNSDirectorate Change
7th Aug 20184:14 pmRNSDirector/PDMR Shareholding
1st Aug 20189:52 amRNSDirectorate Change
1st Aug 20189:24 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.